Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$872K Hold
16,632
– – 0.27% 106
2026
Q1
$918K Sell
16,632
-2,275
-12% -$123K 0.3% 94
2025
Q4
$927K Sell
18,907
-480
-2% -$22.4K 0.3% 85
2025
Q3
$837K Buy
+19,387
New +$757K 0.29% 97

Other funds holding GSK

Tred Avon Family Wealth's GSK Position: Q2 2026 in Review

Tred Avon Family Wealth held its GSK (GSK) position steady in Q2 2026 at 16,632 shares worth $872K. The position accounts for 0.27% of the portfolio, ranked #106.

Tred Avon Family Wealth first reported a position in GSK in Q3 2025 and has held it in 4 quarters since. The position peaked at $927K in Q4 2025. 1,045 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Tred Avon Family Wealth held 16,632 shares of GSK worth $872K as of Q2 2026.
  • Tred Avon Family Wealth left its GSK share count unchanged in Q2 2026.
  • GSK made up 0.27% of Tred Avon Family Wealth's portfolio in Q2 2026, its #106 holding.
  • Tred Avon Family Wealth first reported a position in GSK in Q3 2025 and has held it in 4 quarters since.
  • Tred Avon Family Wealth's GSK position peaked at $927K in Q4 2025.
  • 1,045 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Tred Avon Family Wealth's 13F filing for Q2 2026, filed 10 Aug 2026.